A video posted on the Transfusion News website describes the use of immunomodulation therapy to help manage thrombotic thrombocytopenic purpura, or TTP, which is a rare but serious blood disorder that can cause catastrophic damage if not quickly diagnosed and treated. The video points out that earlier administration of rituximab, often with corticosteroids, may result in better patient outcomes. Progress in the treatment of TTP is discussed in an editorial and two reports appearing in the December issue of "Transfusion." Transfusion News is produced through a partnership between Ortho Clinical Diagnostics and AABB. The site features videos, articles, breaking news and commentary from transfusion and cellular therapy experts. Transfusion News may be accessed through the website for the journal "Transfusion," under "Special Features," or directly at http://www.transfusionnews.com.
Published in Brief: